Effect of Annona Muricata on CD8 and Granzyme-b Expression in Severe Plasmodium berghei Anka Infected Swiss Mice

Registration ID: IJNRD_180329

Published ID: IJNRD2008038

DOI: Click Here to Get

Abdulkarim Abdullah Mohammed Amammish , Kis Djamiatun , Muflihatul Muniroh , Dik Puspasari

Annona muricata, P. berghei Anka, granzyme B, CD8

Several studies have reported the role of T cells in Plasmodium berghei ANKA (PbA) that related with the blood and liver patology. Granzyme B (GzmB) is a serine protease released by CD8+ T cells and natural killer cells during cellular immune response, The purpose of these study to determine the effect of Annona muricata leaf-ethanolic exract (AME) on GzmB and CD8-expression-score in spleens of PbA-infected-Swiss-mice. This experimental study used randomized post test only control group design. Thirty six female Swiss mice were divided into 6 groups. C1-group was control-healthy mice, G1 and G2-groups were healthy-mice treated with AME dosage 100 and 150 mg/kg BW/day for 14-day-period. C2-group was control-PbA-infected-group. G3 and G4-groups received AME dosage 100 and 150 mg/kg BW, respectively for 7-day-pre and post-PbA-infection. GzmB and CD8 in the spleen stained by immunohistochemistry-method, then two-pathology-anatomy-experts determined Allred-score by using light microscope. Statistical analyzes used were One-way-ANOVA-test followed by post-hoc-test, and. Pearson-correlation-test. G4 and C1-groups had no significant different GzmB-expression-score (5.60 ± 0.46 and 4.10 ± 1.27; p = 0.134), while those of G3 and C2-groups (6.03 ± 0.48 and 6.70 ± 0.99) were significantly higher than C1-group (p = 0.015 and p = 0.012). AME (150mg/kg BW/day)-treatment associated with GzmB-expression-normal score during severe-PbA-infection. G3, G4 and C2-groups (5.03 ± 0.79; 6.20 ± 1.46 and 6.60 ± 2.77) had no significant different CD8-expression-score compare to C1-group (3.80 ± 2.60; p = 0.829; p = 0.284 and p = 0.150). The correlation score of GzmB and CD8 expression was not found in healthy Swiss mice infected with PbA (r = -0.248; p = 0.158). AME in dose of 150 mg/kg BW/day-treatment normalize GzmB-expression-score of severe-PbA-infected-Swiss-mice, however AME at any dose studied have no influence on CD8- expression-score of those mice

Published Paper   E-Certificate

Abdulkarim Abdullah Mohammed Amammish, Kis Djamiatun, Muflihatul Muniroh, & Dik Puspasari (August-2020). Effect of Annona Muricata on CD8 and Granzyme-b Expression in Severe Plasmodium berghei Anka Infected Swiss Mice. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 5(8), 338-346. https://ijnrd.org/papers/IJNRD2008038.pdf

Volume 5 Issue 8, August-2020

Pages : 338-346

Paper Reg. ID: IJNRD_180329

Published Paper Id: IJNRD2008038

Downloads: 000121986

Research Area: Medical Science

Country: Semarang, Indonesia, Indonesia

Published Paper PDF: https://ijnrd.org/papers/IJNRD2008038.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2008038

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details